Prelude Therapeutics
Price & Volume
Stats
See moreOpen | $1.65 |
Previous Close | $1.67 |
Day Range | $1.60-$1.69 |
52W Range | $0.61-$4.22 |
Market Cap | $104.9M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $10.5M |
Revenue Growth (YoY) | 116.7% |
Gross Profit (12 Mos) | $10.5M |
Diluted EPS | -$1.47 |
News
See moreYahoo Finance • 2 days ago
PRLD Investors Have Opportunity to Join Prelude Therapeutics Incorporated Fraud Investigation with the Schall Law Firm
Yahoo Finance • 9 days ago
Targeted Cancer Therapies Gain Momentum as Precision Market Surges Past $106B
Yahoo Finance • 17 days ago
Prelude Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
About
CEO | Dr. Krishna Vaddi D.V.M., Ph.D. |
CFO | Mr. Bryant David Lim J.D. |
Address | 175 Innovation Boulevard, Wilmington, DE, United States, 19805 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 131 |
